THE EFFECT OF MEMBRANE-CHARACTERISTICS ON TUMOR-NECROSIS-FACTOR KINETICS DURING HEMODIALYSIS

被引:52
作者
GHYSEN, J
DEPLAEN, JF
DESTRIHOU, CV
机构
[1] Department of Nephrology, University of Louvain Medical School, Brussels
关键词
Dialysis amyloidosis; Dialysis membrane; Tumour necrosis factor; ±[!sub]2[!/sub] Microglobulin;
D O I
10.1093/ndt/5.4.270
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
We measured serum β2-M and TNFα before and after a 4-h haemodialysis performed on two membranes with different characteristics, either cuprophane (n = 40) or polyacrylonitrile (AN69) (n = 31). Kinetic studies including determinations at 0, 15, 30, 60 and 240 min were also performed during haemodialysis sessions on cuprophane (n = 14) and AN69 (n = 12). After a 240-min haemodialysis, TNFα increased on cuprophane (21.95 ± 3.46 to 37.20 ± 4.60 pg/ml, P< 0.001) but remained stable on AN69 (16.70 ±2.60 to 19.90±2.90 pg/ml, NS). Kinetic studies revealed that on cuprophane, β2-M increased progressively from 40.72 ± 4.41 to 45.71 ±4.77 mg/l (P<0.001) at 240 min with a significant increase already noted at 60 min. TNFI remained stable during the first 60 min but increased significantly at 240 min (34.14 ± 6.60 to 49.71 ± 8.78 pg/ml, P<0.001). The percentage increment in TNFI (50.5%) was significantly greater at 240 min than the percentage increment in β2M (13.4%), a finding suggestive of net generation of TNFI. On AN69, β2-M decreased progressively from 31.82 ± 2.70 to 27.30±2.26mg/l (P<0.001). TNFI a decreased transiently at 15 min but returned subsequently to control values (0 and 240 min: 25.00 ± 3.81 and 29.75 ± 3.59 pg/ml respectively, NS). Our data suggest a net release of TNFα during cuprophane but not during polyacrylonitrile haemodialysis. This release might play a role in the stimulation of β2-M production and thus in the genesis of dialysis amyloidosis. © 1990 European Dialysis and Transplant Association-European Renal Association.
引用
收藏
页码:270 / 274
页数:5
相关论文
共 15 条
  • [1] ENHANCED SERUM LEVELS OF BETA-2-MICROGLOBULIN, NEOPTERIN, AND INTERFERON-GAMMA IN PATIENTS TREATED WITH RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA
    AULITZKY, WE
    TILG, H
    HEROLD, M
    BERGER, M
    VOGEL, W
    JUDMAIER, G
    GASTL, G
    MULL, B
    FLENER, R
    WIEGELE, J
    PICHLER, E
    DENZ, H
    BOHEIM, E
    AULITZKY, WK
    HUBER, C
    [J]. JOURNAL OF INTERFERON RESEARCH, 1988, 8 (05): : 655 - 664
  • [2] BEUTLER B, 1987, NEW ENGL J MED, V316, P379
  • [3] CARPAL-TUNNEL SYNDROME AND TYPE OF DIALYSIS MEMBRANE
    CHANARD, J
    BINDI, P
    LAVAUD, S
    TOUPANCE, O
    MAHEUT, H
    LACOUR, F
    [J]. BRITISH MEDICAL JOURNAL, 1989, 298 (6677) : 867 - 868
  • [4] RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR INCREASES MESSENGER-RNA LEVELS AND SURFACE EXPRESSION OF HLA-A,B ANTIGENS IN VASCULAR ENDOTHELIAL-CELLS AND DERMAL FIBROBLASTS INVITRO
    COLLINS, T
    LAPIERRE, LA
    FIERS, W
    STROMINGER, JL
    POBER, JS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (02) : 446 - 450
  • [5] CACHECTIN TUMOR NECROSIS FACTOR STIMULATES COLLAGENASE AND PROSTAGLANDIN-E2 PRODUCTION BY HUMAN SYNOVIAL-CELLS AND DERMAL FIBROBLASTS
    DAYER, JM
    BEUTLER, B
    CERAMI, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (06) : 2163 - 2168
  • [6] DESTRIHOU CV, 1988, NEPHROL DIAL TRANSPL, V3, P552
  • [7] GOLDMAN M, 1988, NEPHROL DIAL TRANSPL, V3, P551
  • [8] LONNEMANN G, 1987, NEW ENGL J MED, V317, P963
  • [9] LONNEMANN G, 1988, KIDNEY INT, V33, P229
  • [10] DETECTION OF CIRCULATING TUMOR NECROSIS FACTOR AFTER ENDOTOXIN ADMINISTRATION
    MICHIE, HR
    MANOGUE, KR
    SPRIGGS, DR
    REVHAUG, A
    ODWYER, S
    DINARELLO, CA
    CERAMI, A
    WOLFF, SM
    WILMORE, DW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (23) : 1481 - 1486